Document is current
Any future updates will be listed below
-
Authors
Melgosa Ramos, Francisco Javier https://orcid.org/0000-0003-2121-6727
Pérez, Carlos Abril https://orcid.org/0000-0002-6454-2971
Climent, Santiago Guillén https://orcid.org/0000-0001-7542-2214
Palacios, María Matellanes https://orcid.org/0000-0002-6228-3494
Ginés, Juncal Roca https://orcid.org/0000-0002-6199-7698
Abad, Javier Sabater https://orcid.org/0000-0002-1202-3897
Petit, Eduardo Bernia https://orcid.org/0000-0001-6449-2284
Esquembre, Andrés Casanova https://orcid.org/0000-0002-0134-4564
Corrales, Andrea Estébanez https://orcid.org/0000-0002-5700-6281
Delgado, Victor González https://orcid.org/0000-0002-0330-7599
- License Information
-
More Information
This article is maintained by: Elsevier
Article Title: Mid-term effectiveness, safety, and potential predictors of response of upadacitinib in patients with moderate-to-severe atopic dermatitis: a multicenter observational retrospective study
Journal Title: Anais Brasileiros de Dermatologia
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.abd.2024.10.009
Content Type: article
Copyright: © 2025 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U.
